Ubs Group Ag Bristol Myers Squibb CO Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ubs Group Ag holds 6,553,359 shares of BMY stock, worth $349 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

6,553,359

Previous 301,427 2074.11%

Holding current value

$349 Million

Previous $16.3 Million 1564.99%

% of portfolio

0.07%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $42.8 Million - $56.4 Million	-1,063,674 Reduced 13.96%	6,553,359 $272 Million
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $132 Million - $149 Million	2,745,207 Added 56.35%	7,617,033 $413 Million
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $99.3 Million - $118 Million	-2,048,229 Reduced 29.6%	4,871,826 $250 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $44.2 Million - $49.4 Million	763,736 Added 12.41%	6,920,055 $402 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $10.9 Million - $12.1 Million	170,841 Added 2.85%	6,156,319 $394 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $55.1 Million - $62.5 Million	-838,733 Reduced 12.29%	5,985,478 $415 Million
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $93.1 Million - $110 Million	1,359,771 Added 24.88%	6,824,211 $491 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $55,700 - $32.9 Million	-428,464 Reduced 7.27%	5,464,440 $388 Million
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $36.9 Million - $40.7 Million	-508,349 Reduced 7.94%	5,892,904 $454 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $67.3 Million - $80.6 Million	-1,093,879 Reduced 14.59%	6,401,253 $467 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1.23 Million - $1.43 Million	-22,933 Reduced 0.31%	7,495,132 $467 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $20 Million - $23.4 Million	338,260 Added 4.71%	7,518,065 $445 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $75.8 Million - $82.6 Million	1,224,518 Added 20.56%	7,179,805 $480 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $44.2 Million - $49.7 Million	-744,320 Reduced 11.11%	5,955,287 $376 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $36.7 Million - $41.6 Million	635,824 Added 10.49%	6,699,607 $416 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $1.04 Million - $1.15 Million	18,096 Added 0.3%	6,063,783 $366 Million
Q2 2020 Jul 31, 2020	SELL	$54.82 - $64.09 $98.6 Million - $115 Million	-1,799,488 Reduced 22.94%	6,045,687 $355 Million
Q1 2020 May 01, 2020	SELL	$46.4 - $67.43 $108 Million - $156 Million	-2,318,074 Reduced 22.81%	7,845,175 $437 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $174 Million - $227 Million	3,538,088 Added 53.4%	10,163,249 $652 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $38.6 Million - $45.8 Million	-903,304 Reduced 12.0%	6,625,161 $336 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $92.8 Million - $103 Million	2,080,097 Added 38.18%	7,528,465 $341 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $13.5 Million - $16.1 Million	-299,069 Reduced 5.2%	5,448,368 $260 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $116 Million - $150 Million	-2,369,608 Reduced 29.19%	5,747,437 $299 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $17.4 Million - $19.7 Million	316,058 Added 4.05%	8,117,045 $504 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $4.55 Million - $5.67 Million	-89,990 Reduced 1.14%	7,800,987 $432 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $44.7 Million - $51.5 Million	-746,728 Reduced 8.64%	7,890,977 $499 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $64.4 Million - $70.2 Million	1,074,384 Added 14.21%	8,637,705 $529 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $73.5 Million - $84.9 Million	-1,331,405 Reduced 14.97%	7,563,321 $482 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,364,066 Added 18.11%	8,894,726 $496 Million
Q1 2017 Nov 14, 2017	BUY	N/A	7,530,660	7,530,660 $410 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account